Retirement Systems of Alabama raised its holdings in Becton, Dickinson and Company (NYSE:BDX) by 4.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 161,834 shares of the medical instruments supplier’s stock after buying an additional 7,358 shares during the period. Retirement Systems of Alabama owned about 0.08% of Becton, Dickinson and worth $31,575,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of BDX. BlackRock Inc. raised its stake in Becton, Dickinson and by 2,427.8% in the first quarter. BlackRock Inc. now owns 16,542,028 shares of the medical instruments supplier’s stock valued at $3,034,470,000 after buying an additional 15,887,611 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Becton, Dickinson and by 5.3% during the first quarter. Vanguard Group Inc. now owns 15,902,168 shares of the medical instruments supplier’s stock worth $2,917,094,000 after purchasing an additional 796,034 shares during the last quarter. Point72 Asset Management L.P. purchased a new position in shares of Becton, Dickinson and during the first quarter worth about $101,993,000. Waverton Investment Management Ltd purchased a new position in shares of Becton, Dickinson and during the second quarter worth about $68,448,000. Finally, Cantillon Capital Management LLC grew its holdings in shares of Becton, Dickinson and by 30.3% during the first quarter. Cantillon Capital Management LLC now owns 1,344,427 shares of the medical instruments supplier’s stock worth $246,622,000 after purchasing an additional 312,926 shares during the last quarter. Institutional investors own 87.42% of the company’s stock.

Several brokerages have issued reports on BDX. Barclays PLC reaffirmed an “equal weight” rating and set a $210.00 price objective (up previously from $205.00) on shares of Becton, Dickinson and in a report on Thursday, August 10th. BidaskClub lowered Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Stifel Nicolaus reaffirmed a “buy” rating on shares of Becton, Dickinson and in a report on Wednesday, August 9th. Zacks Investment Research lowered Becton, Dickinson and from a “buy” rating to a “hold” rating in a report on Monday, August 7th. Finally, Cowen and Company reaffirmed an “outperform” rating and set a $230.00 price objective (up previously from $200.00) on shares of Becton, Dickinson and in a report on Monday, July 10th. One research analyst has rated the stock with a sell rating, five have given a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $195.79.

ILLEGAL ACTIVITY WARNING: This article was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/09/07/retirement-systems-of-alabama-has-31-58-million-holdings-in-becton-dickinson-and-company-bdx.html.

Becton, Dickinson and Company (NYSE:BDX) opened at 199.23 on Thursday. Becton, Dickinson and Company has a 12-month low of $161.29 and a 12-month high of $206.63. The stock has a market cap of $45.34 billion, a price-to-earnings ratio of 57.70 and a beta of 1.06. The company’s 50 day moving average price is $200.18 and its 200-day moving average price is $190.58.

Becton, Dickinson and (NYSE:BDX) last released its earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 EPS for the quarter, beating the consensus estimate of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The business had revenue of $3.04 billion during the quarter, compared to analyst estimates of $3.06 billion. During the same period in the prior year, the business earned $2.35 earnings per share. The business’s quarterly revenue was down 5.1% on a year-over-year basis. On average, analysts forecast that Becton, Dickinson and Company will post $9.46 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 8th will be paid a dividend of $0.73 per share. This represents a $2.92 annualized dividend and a yield of 1.47%. The ex-dividend date of this dividend is Thursday, September 7th. Becton, Dickinson and’s dividend payout ratio is presently 83.43%.

In related news, insider Thomas E. Polen, Jr. sold 5,971 shares of the stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $197.41, for a total transaction of $1,178,735.11. Following the completion of the sale, the insider now directly owns 12,861 shares of the company’s stock, valued at $2,538,890.01. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Linda M. Tharby sold 4,695 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $200.48, for a total transaction of $941,253.60. Following the sale, the executive vice president now directly owns 18,670 shares of the company’s stock, valued at $3,742,961.60. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,605 shares of company stock valued at $9,718,986. Company insiders own 1.40% of the company’s stock.

Becton, Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Stock Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related stocks with our FREE daily email newsletter.